Filtered By:
Procedure: Percutaneous Coronary Intervention
Countries: Poland Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

IJERPH, Vol. 20, Pages 6145: Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
This study outlines reasons to initiate OAC treatment in very high-risk patients in clinical practice.
Source: International Journal of Environmental Research and Public Health - June 16, 2023 Category: Environmental Health Authors: Bernadetta Bielecka Iwona Gorczyca-G łowacka Agnieszka Ciba-Stemplewska Beata Wo żakowska-Kapłon Tags: Article Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research

Frequency and predictors of diagnostic coronary angiography and percutaneous coronary intervention related to stroke
CONCLUSIONS: Based on the large national registry, PCI ± DCA is associated with fewer risk factors and lower rate of periprocedural strokes than isolated DCA.PMID:34472076 | DOI:10.33963/KP.a2021.0100
Source: Kardiologia Polska - September 2, 2021 Category: Cardiology Authors: Bart łomiej Staszczak Krzysztof P Malinowski Wojciech Wa ńha Zbigniew Siudak Magdalena J ędrychowska Micha ł Susuł S ławomir Surowiec Szymon Darocha Andrzej Surdacki Marcin Kurzyna Wojciech Wojakowski Jacek Legutko Krzysztof Bartu ś Stanis ław Bar Source Type: research

Immediate mechanical thrombectomy with DynaCT evaluation after percutaneous coronary intervention complicated with acute ischemic stroke
Kardiol Pol. 2021 Jun 24. doi: 10.33963/KP.a2021.0043. Online ahead of print.NO ABSTRACTPMID:34166519 | DOI:10.33963/KP.a2021.0043
Source: Polish Heart Journal - June 24, 2021 Category: Cardiology Authors: Tomasz Tokarek Dominika Dykla Tadeusz Popiela Bart łomiej Łasocha Stanis ław Bartuś Łukasz Rzeszutko Source Type: research

A comparison of clinical characteristics, the in-hospital course, and 12-month prognosis in women and men with chronic coronary syndromes.
Conclusions: Women and men with CCS differ in the incidence of risk factors and revascularization treatments. Men were found to have a higher frequency of 12-month death and composite endpoint follow-up. However, sex is not independent predictor of 12-month outcomes. PMID: 33463985 [PubMed - as supplied by publisher]
Source: Polish Heart Journal - January 15, 2021 Category: Cardiology Authors: Duda-Pyszny D, Trzeciak P, Desperak P, Zembala M, Gąsior M Tags: Kardiol Pol Source Type: research

Long-term clinical outcomes in patients with unstable angina undergoing percutaneous coronary interventions in a contemporary registry data from Poland
Conclusion Three-year prognosis in unstable angina was considerable better in comparison with NSTEMI. On the contrary, after adjustment for baseline differences, the outcomes (death, MI, MACE) in unstable angina and stable angina patients were comparable.
Source: Coronary Artery Disease - April 9, 2020 Category: Cardiology Tags: PCI Source Type: research

Ability to Suppress TGF- β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
Conclusion: This study suggests that a clinically efficacious cardiovascular Chinese herbal medicine (DLP) can be successfully repurposed to treat a lung disease in pulmonary fibrosis guided by TCM theory. Our comparative study between DLP and DHP demonstrated a critical requirement of suppressing both pro-inflammatory and pro-fibrotic pathways for the treatment of pulmonary fibrosis, supporting that a multi-component prescription capable of “removing both phlegm and blood stasis” will better achieve co-protection of heart and lung in PHD. Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic ...
Source: Frontiers in Pharmacology - April 23, 2019 Category: Drugs & Pharmacology Source Type: research